Pa. Biotech Firm in Deal with Univ. Of Md, Baltimore As $400m Biopark Set to Open

Summary


A new research partnership has blossomed for the University of Maryland, Baltimore with Pennsylvania-based biotech Acceptys Inc. - the latest deal sprung from the multimillion-dollar BioPark the university is building near its West Baltimore campus.

Acceptys, which focuses on the use of human antibodies in the treatment and prevention of disease, has inked a one-year agreement with the Department of Microbiology and Immunology at the university's medical school, funded in part by a $100,000 state grant to the school.

See the full content of this document

Extract


Pa. Biotech Firm in Deal with Univ. Of Md, Baltimore As $400m Biopark Set to Open

The company is one of 10 firms that will set up shop in the BioPark's $36 million Building One, which opens its doors to tenants this month. Deal...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company